Brief: Kolon Tissuegene To Conduct Capital Increase Of 60 Billion Won For Operational Funds
06/03/2026 09:01
Kolon TissueGene Inc 950160.KQ: KOLON TISSUEGENE: TO CONDUCT CAPITAL INCREASE OF 60 BILLION WON FOR OPERATIONAL FUNDS Source text: [ID:] Further company coverage: 950160.KQ
Recent news on Kolon TissueGene
See all newsBrief: Kolon Tissuegene To Conduct Capital Increase Of 60 Billion Won For Operational Funds
Brief: Kolon Tissuegene Highlights Long-Term Safety Data And Potential U.S. FDA Pathway For Tg-C At Oarsi World Congress
Brief: Kolon Tissuegene To Conduct Capital Increase Of 44 Billion Won For Operational Funds
Brief: Kolon Tissuegene To Conduct Capital Increase Of 48 Billion Won For Operational Funds
Brief: Kolon Corp 2017/2018 Financial Statements Are Subject To Change Depending On Audit Results